Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients
- 28 March 2021
- journal article
- research article
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (3), 795-801
- https://doi.org/10.1016/j.dsx.2021.03.022
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Management of Diabetic Ketoacidosis: A Summary of the 2013 Joint British Diabetes Societies GuidelinesJournal of the Intensive Care Society, 2014
- Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)Journal of Diabetes, 2013
- Severe Hypoglycemia and Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Results From the T1D Exchange Clinic RegistryJournal of Clinical Endocrinology & Metabolism, 2013
- Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic reviewBMJ, 2011
- Age-Related Differences in the Frequency of Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and AdolescentsDiabetes Care, 2010
- Diabetic ketoacidosis at diagnosis in Austrian children in 1989–2008: a population-based analysisDiabetologia, 2010
- Glucocorticoid-Induced HyperglycemiaEndocrine Practice, 2009
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009
- Clinical characteristics and outcomes of diabetic ketoacidosis in Pakistani adults with Type 2 diabetes mellitusDiabetic Medicine, 2004
- Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosisDiabetologia, 2001